The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 34, Issue 1, Pages 199-210
Publisher
Oxford University Press (OUP)
Online
2012-10-07
DOI
10.1093/carcin/bgs319
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor-Negative Mammary Carcinogenesis in Polyoma Middle T Mice
- (2012) K. Tran et al. Cancer Prevention Research
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining
- (2011) C. DeSantis et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin
- (2011) Michael A. Pereira et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor microenvironment and progression
- (2011) Harold F. Dvorak et al. JOURNAL OF SURGICAL ONCOLOGY
- Effects and Mechanisms of the Combination of Suberoylanilide Hydroxamic Acid and Bortezomib on the Anticancer Property of Gemcitabine in Pancreatic Cancer
- (2011) Jun Kyu Lee et al. PANCREAS
- The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines
- (2011) Andrea Morandi et al. PLoS One
- Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids
- (2010) Fredika M. Robertson et al. CANCER
- Deploying Mouse Models of Pancreatic Cancer for Chemoprevention Studies
- (2010) P. J. Grippo et al. Cancer Prevention Research
- Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
- (2010) K. T. Liby et al. Cancer Prevention Research
- Anti-inflammatory Agents: Present and Future
- (2010) Charles A. Dinarello CELL
- Nonresolving Inflammation
- (2010) Carl Nathan et al. CELL
- Cancer and Inflammation: Implications for Pharmacology and Therapeutics
- (2010) F Balkwill et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
- (2010) Evette S. Radisky et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Triterpenoids CDDO-Methyl Ester or CDDO-Ethyl Amide and Rexinoids LG100268 or NRX194204 for Prevention and Treatment of Lung Cancer in Mice
- (2009) K. Liby et al. Cancer Prevention Research
- Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor
- (2009) A. Patsialou et al. CANCER RESEARCH
- Colony-Stimulating Factor-1 Receptor Inhibitors for the Treatment of Cancer and Inflammatory Disease
- (2009) Sharmila Patel et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- A comprehensive catalogue of somatic mutations from a human cancer genome
- (2009) Erin D. Pleasance et al. NATURE
- Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy
- (2008) Mayumi Ono CANCER SCIENCE
- Prevention and Treatment of Experimental Estrogen Receptor-Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268
- (2008) K. Liby et al. CLINICAL CANCER RESEARCH
- Macrophages define the invasive microenvironment in breast cancer
- (2008) Jeffrey W. Pollard JOURNAL OF LEUKOCYTE BIOLOGY
- Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model
- (2008) K. Almholt et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started